Future of cardiac surgery: Minimally invasive techniques in sutureless valve resection

Future Cardiology

Volumn 5, Issue 5, 2009, Pages 443-452

  Folliguet, Thierry ^a   Dibie, Alain ^b   Laborde, François ^b  

^a Department of Cardiovascular Surgery L'institut Mutualiste Montsouris ^*  (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Pathological analysis; Perceval sutureless valve; Percutaneous aortic valve replacement

Indexed keywords

DACRON; NITINOL; WARFARIN;

ANTICOAGULATION; AORTA STENOSIS; AORTA VALVE REGURGITATION; ATRIOVENTRICULAR BLOCK; BIOPROSTHESIS; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; GASTROINTESTINAL HEMORRHAGE; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HEART TAMPONADE; HEART VALVE PROSTHESIS; HUMAN; MINIMALLY INVASIVE SURGERY; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHESIS MATERIAL; REVIEW; STENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; SUTURELESS VALVE RESECTION; THROMBOEMBOLISM; WOUND INFECTION; AORTA VALVE; AORTIC VALVE STENOSIS; CARDIOVASCULAR SURGERY; DEVICES; HEART VALVE REPLACEMENT; PROCEDURES; SUTURE; TRANSLUMINAL CORONARY ANGIOPLASTY; TRENDS;

ANGIOPLASTY, BALLOON, CORONARY; AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIOVASCULAR SURGICAL PROCEDURES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MINIMALLY INVASIVE SURGICAL PROCEDURES; SUTURES;

EID: 70349215644     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.09.35     Document Type: Review

References (39)

1. Bonow RO, Carabello BA, Kanu C et al.: ACC/AHA 2006 Guidelines for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/Amcrican Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114, E84-E231 (2006).
2. Vahanian A, Baumgartner H, Bax J et al.: Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230-268 (2007).
3. Jamieson WR, Burr LH, Munro AI, Miyagishima RT: Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann. Thorac. Surg. 66, S40-S43
4. Eric Jamieson WR, Marchand MA, Pelletier CL et al.: Structural valve deterioration in mitral replacement surgery: comparison of Carpentier-Edwards supra-annular porcine and perimount pericardial bioprostheses. J. Thorac. Cardiovasc. Surg. 118, 297-304 (1999).
5. Grabenwoger M, Grimm M, Leukauf C et al.: Failure mode of a new pericardial valve prosthesis (Sorin Pericarbon™). A morphological study. Eur. J. Cardiothorac. Surg. 8, 470-476 (1994).
6. Pelletier LC, Carrier M, Leclerc Y, Lepage G, de Guise P, Dyrda I: Porcine versus pericardial bioprostheses: a comparison of late results in 1593 patients (see comments). Ann. Thorac. Surg. 47, 352-361 (1989).
7. Gonzalez-Lavin L, Gonzalez-Lavin J, Chi S, Lewis B, Amini S, Graf D: The pericardial valve in the aortic position ten years later. J. Thorac. Cardiovasc. Surg. 101, 75-80 (1991).
8. Valente M, Ius P, Bortolotti U, Talenti E, Bottio, T, Thiene G: Pathology of the Pericarbon bovine pericardial xenograft implanted in humans. J. Heart Valve Dis. 7, 180-189 (1998).
9. Dunning J, Graham RJ, Thambyrajah J et al.: Stentless vs stented aortic valve bioprostheses: a prospective randomized controlled trial. Eur. Heart J. 28, 2369-2374 (2007).
10. Sjogren J, Gudbjartsson T, Thulin LI: Long-term outcome of the MitroFlow pericardial bioprosthesis in the elderly after aortic valve replacement. J. Heart Valve Dis. 15, 197-202 (2006).
11. Pomar JL, Jamieson WR, Pelletier LC et al.: Mitroflow pericardial bioprosthesis experience in aortic valve. replacement ≥ 60 years of age. Ann. Thorac Surg. 66, S53-S56 (1998).
12. Dellgren G, David TE, Raanaai E et al.: Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount™ pericardial bioprosthesis. J. Thorac. Cardiovasc. Surg. 124, 146-154 (2002).
13. David TE, Puschmann R, Ivanov J et al.: Aortic valve replacement with stentless and stented porcine valves: a case-match study. J. Thorac. Cardiovasc. Surg. 116, 236-241 (1998).
14. Repossini A, Kotelnikov I, Bouchikhi R et al.: Single-suture line placement of a pericardial stentless valve. J. Thorac. Cardiovasc. Surg. 130, 1265-1269 (2005).
15. Beholz S, Dushe S, Konertz W: The Freedom SOLO valve: superior hemodynamic results with a new stentless pericardial valve for aortic valve replacement. J. Heart Valve Dis. 16, 49-55; discussion 55 (2007).
16. Casabona R, De Paulis R, Zattera GF et al.: Stentless porcine and pericardial valve in aortic position. Ann. Thorac. Surg. 54, 681-684; discussion 685 (1992).
17. de Kerchove L, Glineur D, El Khoury G, Noirhomme P: Stentless valves for aortic valve replacement: where do we stand? Curr. Opin. Cardiol. 22, 96-103 (2007).
18. Kunadian B, Vijayalakshmi K, Thornley AR et al.: Meta-analysis of valve hemodynamics and left ventricular mass regression for stentless versus stented aortic valves. Ann. Thorac. Surg. 84, 73-78 (2007).
19. Bove T, Van Belleghem Y, Francois K et al.: Stentless and stented aortic valve replacement in elderly patients: factors affecting midterm clinical and hemodynamical outcome. Eur. J. Cardiothorac. Surg. 30, 706-713 (2006).
20. Kallikourdis A, Jacob S: Is a stentless aortic valve superior to conventional bioprosthetic valves for aortic valve replacement? Interact Cardiovasc. Thorac. Surg. 6, 665-672 (2007).
21. Cox JL, Ad N, Myers K, Gharib M, Quijano RC: Tubular heart valves: a new tissue prosthesis design - preclinical evaluation of the 3F aortic bioprosthesis. J. Thorac. Cardiovasc. Surg. 130, 520-527 (2005).
22. Shrestha M, Khaladj N, Bara C et al.: A staged approach towards interventional aortic valve implantation with a sutureless valve: initial human implants. Thorac. Cardiovasc. Surg. 56, 398-400 (2008).
23. Cribier A, Eltchaninoff H, Bash A et al.: Percuraneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006-3008 (2002).
24. Martens S, Ploss A, Sirat S, Miskovic A, Moritz A, Doss M: Sutureless aortic valve replacement with the 3f enable aortic bioprosthesis. Ann. Thorac. Surg. 87, 1914-1917 (2009).
25. Mueller XM, von Segesser LK: A new equine pericardial stentless valve. J. Thorac. Cardiovasc. Surg. 125, 1405-1411 (2003).
26. Cribier A, Eltchaninoff H, Tron C et al.: Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J. Am. Colt Cardiol. 43, 698-703 (2004).
27. Cribier A, Eltchaninoff H, Tron C et al.: Treatment of calcific aortic stenosis with the percutaneous cart valve: mid-term follow-up from the initial feasibility studies: the French experience. J. Am. Coll. Cardiol. 47, 1214-1223 (2006),
28. Webb JG, Pasupati S, Humphries K et al.: Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116, 755-763 (2007).
29. Webb JG, Chandavimol M, Thompson CR et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842-850 (2006).
30. Grube E, Schuler G, Buellesfeld L et al.: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007).
31. Ye J, Cheung A, Lichtenstein SV et al.: Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur. J. Cardiothorac. Surg. 31, 16-21 (2007).
32. Walther T, Falk V, Kempfert J et al.: Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur. J. Cardiothorac. Surg. 33, 983-988 (2008).
33. Dewey TM, Brown D, Ryan WH et al.: Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J. Thorac. Cardiovasc. Surg. 135, 180-187 (2008).
34. Mehra RH, Grab JD. O'Brien SM et al.: Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 114, 2208-2216; quiz 2208 (2006).
35. Svensson LG, Dewey T, Kapadia S et al.: United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann. Thorac. Surg. 86, 46-54; discussion 54-55 (20080.
36. Walther T, Simon P, Dewey T et al.: Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116, 1240-1245 (2007).
37. Rosengart TK, Feldman T, Borger MA et al.: Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 117, 1750-1767 (2008).
38. Dewey TM, Brown DL, Das TS et al.: High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann. Thorac. Surg. 86, 1450-1456; discussion 1456-1457 (2008).
39. Vahanian A, Alfieri O, Al-Attar N et al.: Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European association of cardio-thoracic surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). EuroIntervention 4, 193-199 (2008).